Brief: Elekta Near-Term Sees Lower Sales In China And U.S.
Feb 21 (Reuters) - Elekta AB (publ) EKTAb.ST :
* NEAR-TERM WE EXPECT LOWER SALES IN CHINA AND THE U.S., WE
ARE
ADJUSTING OUR FULL YEAR GUIDANCE
* FOR FULL YEAR OF 2024/25, WE EXPECT NET SALES TO BE
BROADLY
STABLE AND EBIT MARGIN TO BE LOWER, COMPARED TO FULL YEAR
2023/24
* BEYOND THIS FISCAL YEAR, WE ARE TARGETING AN EBIT MARGIN
OF 14%
OR HIGHER
Source text: ID:nMFN9yK4Dr
Further company coverage: EKTAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))